搜索结果: 1-15 共查到“医学 Alzheimer”相关记录55条 . 查询时间(0.082 秒)
Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive declin...
《The overview of studies on huperzine A: a natural drug for the treatment of Alzheimer's disease》
中国科学院 上海药物研究所 阿尔茨海默病
<
2023/2/22
《The overview of studies on huperzine A: a natural drug for the treatment of Alzheimer's disease》
附属瑞金医院王刚教授团队聚焦阿尔茨海默病及相关痴呆（Alzheimer’ s disease and related dementias, ADRD）与医疗保险、医疗资源相关性研究，并提出全新管理模式，目前该研究成果在线发表于神经病学专业领域权威医学杂志Alzheimer‘s & Dementia，论文标题为：The impacts of health insurance and resource...
首都医科大学宣武医院贾建平教授团队《Alzheimer’s & Dementia》报道中国阿尔茨海默病家系的重要遗传机制（图）
首都医科大学宣武医院 贾建平 教授 Alzheimer’s Dementia 中国阿尔茨海默病家系 重要遗传机制
<
2020/3/9
2020年1月8日，首都医科大学宣武医院贾建平教授团队在《Alzheimer’s & Dementia》杂志在线发表了题为“PSEN1, PSEN2 and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease”的论文。该研究对404个中国家族性阿尔茨海默病（Familial Alzheimer’s dis...
首都医科大学宣武医院贾建平教授团队《Alzheimer's & Dementia》提出外周血外泌体诊断阿尔茨海默病的生物标志物新方法（图）
首都医科大学 宣武医院 贾建平 教授 团队 Alzheimer's & Dementia 外周血 外泌体 诊断 阿尔茨海默病 生物 新方法
<
2019/9/19
2019年8月，首都医科大学宣武医院贾建平教授团队在《Alzheimer's & Dementia》（5年IF:13.533）杂志上在线发表题为“Concordance between the assessment of Aβ42,T-tau,and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal...
首都医科大学宣武医院贾建平、赵国光、唐毅《Alzheimer's & Dementia》阐述认知训练可改善血管性轻度认知障碍患者认知功能（图）
首都医科大学宣武医院 认知训练 血管性 轻度认知障碍 患者认知功能
<
2019/4/4
2019年3月，宣武医院贾建平教授团队在《Alzheimer's & Dementia》（5年IF:12.06）上在线发表题为“The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomiz...
首都医科大学宣武医院贾建平教授等在Alzheimer's & Dementia发文揭示中国阿尔茨海默病社会经济负担（图）
首都医科大学宣武医院 贾建平 教授 Alzheimer's & Dementia 中国阿尔茨海默病 社会经济负担
<
2018/7/9
2018年4月，首都医科大学宣武医院贾建平教授团队在《Alzheimer's & Dementia》(IF：13.294)发表文章，论文题目为“The cost of Alzheimer's disease in China and re-estimation of costs worldwide”。该研究联合国内30个省市自治区81家中心，对2015年中国阿尔茨海默病（Alzheimer’s D...
第14届国际阿尔兹海默病和帕金森病大会会议（The 14th International Conference on Alzheimer’s & Parkinson’s Diseases, AD/PDTM 2019）
第14届 阿尔兹海默病 帕金森病 大会会议
<
2018/5/23
第14届国际阿尔兹海默病和帕金森病大会会议 (The 14th International Conference on Alzheimer’s & Parkinson’s Diseases, AD/PDTM 2019) 将于2019年3月26日-- 31日在历史悠久、风光秀丽的欧洲名城葡萄牙首都里斯本举行。本次大会主题：神经退行性疾病机理、临床策略和未来诊疗方法。参会者将包括众多临床医学工作者、基...
New research detects Alzheimer's disease markers in nonhuman primates（图）
Alzheimer disease markers nonhuman primates
<
2017/9/5
As a part of their research to understand the evolution of the human brain and how it differs from those of other primates, scientists from Kent State University discovered proteins associated with Al...
Earlier Alzheimer’s diagnosis may be possible with new imaging compound
Earlier Alzheimer diagnosis imaging compound
<
2016/11/29
By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s disease, their brains already are significantly damaged, dotted with clumps of a destructive protei...
Brain imaging links Alzheimer’s decline to tau protein
Brain imaging Alzheimer’s decline tau protein
<
2016/5/19
A buildup of plaque and dysfunctional proteins in the brain are hallmarks of Alzheimer’s disease. While much Alzheimer’s research has focused on accumulation of the protein amyloid beta, researchers h...
THERAPEUTIC IMPLICATIONS OF COMPUTER MODELS OF BRAIN ACTIVITY FOR ALZHEIMER DISEASE
COMPUTER MODELS
<
2015/7/31
Neural models of large-scale brain processes help to explain many features of neuropsychological syndromes and psychiatric disease. Two associative memory models useful to understand some aspects of c...
Novel regulation of neuronal genes implicated in Alzheimer disease by microRNA
Alzheimer APP BACE1 microRNA post-transcriptional gene regulation amyloid fetal neurons
<
2015/5/21
Alzheimer disease (AD) results, in part, from the excess accumulation of the amyloid-β peptide (Aβ) as neuritic plaques in the brain. The short Aβ peptide is derived from a large transmembrane precurs...
EVALUATION OF GENE REGULATION AND THERAPEUTIC DRUGS RELATED TO ALZHEIMER’S DISEASE IN DEGENERATING PRIMARY CEREBROCORTICAL CULTURES
Alzheimer synapse neurodegeneration primary culture memantine
<
2015/5/21
Alzheimer’s disease (AD) is a neurological disorder defined by the presence of plaques comprised mostly of amyloid-β (Aβ), and neurofibrillary tangles consisting of hyperphosphorylated microtubule ass...
MRI Measures of Neurodegeneration as Biomarkers of Alzheimer's Disease
magnetic resonance imaging (MRI) Alzheimer's disease (AD) mild cognitive impairment (MCI) biomarkers cognitive complaints Alzheimer's Disease Neuroimaging Initiative (ADNI) visual contrast sensitivity
<
2015/5/21
Alzheimer’s disease (AD) is the most common age-related neurodegenerative disease. Many researchers believe that an effective AD treatment will prevent the development of disease rather than treat the...